Plasmids carrying the Epstein-Barr virus (EBV) latent gene obtained with these EBV-based vectors were compared EBNA1 and the EBV latent origin of replication (oriP) stay with another plasmid, not carrying EBNA1 and oriP. cDNAs in transfected human cells as autonomously replicating coding for GM-CSF, IL6, TNF␣, the chloramphenicolacetylextrachromosomal genetic units. They thus might reptransferase (CAT) and the ␤-galactosidase (lacZ) gene resent a suitable tool for cytokine gene introduction into were transfected into the EBV-positive Burkitt's lymphoma human tumor cells with the prospect of therapeutic anticell line BL60 and the EBV-negative B cell lymphoma cell tumor vaccination. The aim of this study was to analyze line BJA-B. EBV-derived vectors permitted a high, host cell whether such plasmids permit stable and efficient independent transfection efficiency and high and host cell expression of cytokine genes in human non-Hodgkin lymindependent levels of expression. After removal of the phoma cells. We tested physical stability and expression selection pressure (hygromycin B) cytokine expression levels of plasmids carrying EBNA1 and oriP for episomal could be detected for several weeks in vitro and in vivo maintenance, immunoglobulin light chain enhancer but, however, declined continuously. These experiments elements for augmentation of expression, and cytokine or suggest that episomal BC-derived vectors represent an marker genes after introduction into human NHL cell lines effective tool for cytokine gene transfer in human lymin vitro and in vivo after inoculation into nude mice. Data phoma cells.
Introduction
ing human cytokine genes. 6 Induction of an antitumor host response by vaccination Malignant lymphomas also represent attractive candiwith genetically modified, cytokine secreting autologous dates for cytokine transfer-mediated immune therapy. tumor cells has been demonstrated in several murine Immunoglobulin (Ig) gene idiotypes expressed on B lymtumor models. In these studies mice were vaccinated, for phoma cells are tumor-specific antigens and thus repinstance, with interferon gamma (IFN␥)-transduced resent individual targets for specific immune therapy. In neuroblastoma cells, 1 interleukin 2 (IL2)-transduced mice a humoral as well as a cellular immune response fibrosarcoma cells 2 or IL2-transduced colon carcinoma have been demonstrated against Ig idiotypes. Furthercells. 3 Other vaccination approaches included transducmore, idiotype immunization led to tumor regression of tion of malignant cells with cDNA coding for granulomurine B cell lymphoma. 7 This effect could be augcyte-macrophage colony-stimulating factor (GM-CSF), mented by systemic administration of IL2 and IFN␥. 8 In IL4, IL7, IL8 or tumor necrosis factor alpha (TNF␣). 4 the murine model the idiotypes themselves have only a Cytokine expression in tumor cells was shown to activate weak immunogenic potential. A pronounced aug-MHC-restricted cytotoxic T cells, lymphokine-activated mentation of idiotype immunogenicity, was achieved by killer (LAK) cells, natural killer (NK) cells and macrouse of idiotype/GM-CSF fusion proteins. 9 Yet, no data phages. 5 These promising animal studies have now exist with regard to augmentation of an immune initiated several clinical phase I/II trials using solid response following cytokine gene transfection into human lymphoma cells. The most widely used gene transfer systems are replication-incompetent retroviruses permitting a high transduction efficiency. Retroviral gene transfer, however, of transduced genes may vary with the integration site shows the maps of the basic vectors. For detailed cloning strategy see Materials and methods. and cell type. In addition, insertional mutagenesis represents a possible hazard. 10 Thus, alternative viral and nonviral gene delivery and expression systems are Transfection of BL60-P7 and BJA-B cells with pKEX-2XR-and BC219-derived expression vectors being explored.
Recently, infectious EBV-based vectors (mini-EBVs) pKEX-CAT, pKEX-IL6 and pKEX-TNF␣ were transfected into the Burkitt's lymphoma cell line BL60-P7 and the were engineered to transfer genes into human B cells.
11
These infectious mini-EBVs carried cis-acting elements of EBV-negative B cell lymphoma cell line BJA-B using electroporation. The number of growing, hygromycin B-EBV necessary for episomal maintenance, amplification and packaging of the vector, not however, any of the resistant clones was determined 3 weeks after electroporation. The stable transfection efficiency was defined as known latent EBV genes associated with transformation. Successful infection of B lymphoblastoid cells from a Fanthe ratio of hygromycin B-resistant clones to viable cells after electroporation. For each cell line and vector type coni anemia group C (FA-C) patient with a mini-EBV vector expressing the normal FACC cDNA could be demontransfection efficiencies were rather similiar, regardless of the given insert. Using the pKEX constructs, average strated. Compared with retrovirus-mediated gene transfer, these mini-EBVs had the advantage of reptransfection efficiency was approximately 1 to 7.1 × 10 4 for BJA-B cells and 1 to 2.5 × 10 6 for BL60-P7 cells. licating episomally in the target cells, thus avoiding the possible hazards of integration into the host cell genome.
The BC219-IL6, BC219-TNF␣, BC219-GM-CSF, BC230a (=BC219-CAT) and BC-DZ17 (=BC219-lacZ) were transHowever, there might still be concerns about the incalculable hazards of working with infectious particles. This fected into BL60-P7 and BJA-B cells by the same procedure. For these vectors the average transfection concern might especially hold true for the cloning of cytokine genes into such vectors, which then might exert pleiefficiency was approximately 1 to 2.4 × 10 4 for BJA-B cells and 1 to 2.7 × 10 4 for BL60-P7 cells. Thus, by comparison otropic growth promoting and growth inhibiting effects.
For ex vivo cytokine transfer in lymphoma (and other with pKEX-2XR, BC219-derived vectors show a 3.2-fold higher transfection efficiency in BJA-B cells and a 92-fold tumor) cells it would be desirable to use potent expression vectors, which have the advantage of episohigher transfection efficiency in BL60-P7 cells (see also Table 2 ). mal replication, but do not represent infectious particles.
In this study we have tested cytokine gene introduction Southern blotting was performed to determine the physical state of the transfected pKEX-plasmids in hygroand expression in human lymphoma cell lines using plasmids containing the Epstein-Barr virus nuclear antigen 1 mycin B-resistant BL60-P7 and BJA-B transfectants. Cellular DNA from four representative BL60-pKEX-CAT (EBNA1) gene and the viral latent origin of replication (oriP) permitting the episomal state of these plasmids and transfectants was digested with BamHI and hybridized with the 32 P-labeled pKEX-CAT DNA (Figure 2a) . BamHI in addition immunoglobulin kappa light chain enhancer elements for augmentation of expression. Results with digestion of pKEX-CAT plasmid results in two fragments of 6.0 and 1.6 kb length, respectively. Thus, after intethese episomal vectors were systematically compared with results obtained with a vector not carrying these gration of the pKEX-CAT plasmid into the BL60 genome in Southern blot analysis, three BamHI fragments are EBV and Ig kappa light chain gene-derived genomic elements.
expected. The total length of these fragments should be at least 7.6 kb (plus the length of adjacent cellular fragments). In all four BL60-pKEX-CAT clones three fragResults ments were detected. The upper band of 5.8 kb size is Construction of expression vectors due to hybridization of the pKEX-CAT plasmid to the The expression vectors pKEX-CAT, pKEX-TNF␣ and pSV2neo-plasmid 12 which had been transfected into this pKEX-IL6 were obtained by cloning cDNAs for the CAT cell line previously. 13 The additional two bands which gene, TNF␣ and IL6 into the pKEX-2XR-plasmid. The differ in size in all transfectants are interpreted to repexpression vectors BC219-IL6, BC219-TNF␣ and BC219-resent integrated pKEX-CAT sequences joined to BL60-GM-CSF were obtained by cloning the cDNAs into the P7 sequences. In all four clones the detected pKEX-CAT plasmid BC219, which replicates episomally after transfragments are shorter than the total length of 7.6 kb of fection due to the presence of the EBV nuclear antigen 1 the pKEX-CAT plasmid. This may be due to a partial (EBNA1) and the EBV latent origin of replication (oriP).
deletion of the plasmid during the integration process Table 1 summarizes the vectors constructed. Figure 1 into the cellular genome. This might underlie the nonexpression of CAT protein of these transfectants (see below) since promoter-CAT gene sequences could be band in all BL60-P7 clones of 5.8 kb is generated from cross-hybridization of the BC230a probe to the pSV2neo-pg/ml for the BJA-B-pKEX-IL6 and from 40 to 2050 pg/ml for the BJA-B-pKEX-TNF␣ clones. In contrast, no plasmid (see above). Figure 2c shows Southern blot analysis of four BJA-B and BL60-BC-TNF␣ transfectants expression could be found in the BL60-P7 cells stably transfected with pKEX-2XR-derived expression vectors which were hybridized with a 32 P-labeled BC219 probe. Again an identical hybridization pattern is found in all (Table 3 ). Cytokine and CAT expression was also measured for BL60-P7 and BJA-B clones stably transfected clones, namely two bands of 12.9 and 2.0 kb which represent the BamHI digested BC-TNF␣ plasmid. The 5.8 kb with BC219-derived vectors. In 10 out of 10 BJA-B and BL60-P7 clones, respectively, high expression levels for fragment in the BL60-clones is again generated by crosshybridization with the pSV2neo-plasmid.
each transfected gene were found. IL6 expression ranged between 900 and 1210 pg/ml, TNF␣ expression between 1350 and 1900 pg/ml, GM-CSF expression between 650 Expression of cytokines and CAT protein in BJA-B and BL60-P7 transfectants and 655 pg/ml and CAT protein expression between 3800 and 5100 pg/ml (Table 3 ). For each pKEX-2XR-derived expression vector, namely pKEX-CAT, pKEX-IL6 and pKEX-TNF␣, 10 stable BL60-
Taken together these data demonstrate that transfection with pKEX-2XR-derived expression vectors leads to P7 and 10 stable BJA-B transfectants were isolated. After 24 h culture in fresh medium, the cytokine concentration quite variable expression patterns differing considerably between transfected clones of the same cell line as well of 1 × 10 6 exponentially growing cells/ml culture medium and CAT protein in 50 g of total extracted
as in between the cell lines BJA-B and BL60-P7, with no detectable expression in the latter. In contrast, transfeccellular protein were measured. CAT expression of the BJA-B-pKEX-CAT clones reached from 90 to 2100 pg/ul. tion with the BC219 vector leads to transfectants with quite similiar expression levels in all BJA-B and BL60-P7 Cytokine concentration was measured from 8 to 700 clones. In addition, the absolute amounts of cytokines or analyze whether transfection of BL60-P7 cells with BC219 vectors leads to altered cytokine expression, BL60-BC219 CAT protein were higher in all BJA-B and BL60-P7 clones transfected with BC219-derived vectors compared to transfectants were examined for their endogenous cytokine expression using ELISA. Untransfected BL60-P7 cells pKEX-2XR-derived transfectants with the exception of BJA-B-pKEX-TNF␣ clones with expression levels compadid not express the cytokines IL6, IL8, IL10 and TNF␣. BL60-BC219 transfectant clones also did not express these rable to those of BJA-B-BC-TNF␣ clones.
cytokines (data not shown). 14-19 However, the use of infectious viruses in gene therapy has also been release of selection pressure. Taken together these data demonstrate a stable cytokine expression reflecting described to be associated with disadvantages, eg insertional mutagenesis inducing secondary cancers, 20 recomthe stable integration of pKEX-2XR-derived expression vectors in BJA-B transfectants without hygromycin B bination events leading to pathogenic infectious agents, 21 induction of an immune response against the viral vecselection.
The stability of cytokine expression of BL60-BC-IL6 tors 22 and, last but not least, the complexity of the manufacturing procedures. transfectants was examined. One BL60-BC-IL6 clone was cultivated in vitro over a period of 9 weeks with and Noninfectious, plasmid-based expression vectors may circumvent several of these problems. These vectors can without hygromycin B selection and IL6 expression was measured weekly in the supernatant of continuously probe introduced into the target cells, for instance by direct inoculation of the DNA (naked DNA approach), after liferating cells using ELISA. While IL6 expression remained stable in BL60-BC-IL6 cells cultivated with hygmixture with polycationic lipids (liposome-mediated gene delivery) or by complexing with polycations such romycin B selection over the whole period, BL60-BC-IL6 transfectants cultivated without hygromycin B showed a as poly-(l-lysine).
23-27
As a rule such plasmid vectors persist in the majority decrease of IL6 expression. After 9 weeks cells expressed only 12.5 pg/ml IL6 in comparison to 456.5 pg/ml in the as episomal elements and permit short-term gene expression. A minority of the transfected plasmids, howfirst week (Table 4) . A similar IL6 expression pattern was found for BL60-BC-IL6 transfectants in vivo. Four nu/nu ever, become integrated by chance into the host cell genome. In contrast, plasmids containing the EBV latent promice were inoculated with 1 × 10 7 BL60-BC-IL6 cells in each flank. After 2, 4 and 6 weeks, mice were killed, tein EBNA1 and in addition the viral latent origin of replication (oriP) are stably maintained after transfection tumor cells were recultivated and IL6 expression was measured after 24 h. IL6 expression decreased from 212. 6 as autonomously replicating episomes. 28 However, no data have been raised with regard to their long-term pg/ml after 2 weeks to 94.3 pg/ml after 5. weeks (Table  5 ). These data demonstrate that under in vivo conditions, stability in vivo. We were interested, whether such EBV-derived vectors without selection pressure, cytokine expression can be achieved only transiently with BC-derived expression might be suitable for cytokine gene expression in lymphoma cells with the prospect of vaccination therapy vectors.
using cytokine-transfected lymphoma cells. Thus, we cloned the cDNAs for different human cytokines and for 33 It has also been found in T lymphocytes of The episomal EBNA1/oriP vectors permitted in general a higher transfection efficiency compared with the patients with chronic EBV infection, 34 in parotid gland ducts, 35 in hairy leukoplakia of the tongue 36 and in pKEX-derived vectors, ie about a three-fold elevated number of stably transfected clones for cell line BJA-B smooth muscle tumors of immunosuppressed children. 37 Thus, a wide spectrum of cells might be infected when and about 90-fold augmented for the BL60 cell line. These results reflected the stable, cell line-independent episousing such mini-EBVs for gene therapy. In addition, since over 90% of the general population harbor the virus, mal maintenance of the EBNA1/oriP vectors during selection of hygromycin B-resistant clones after transfecrecombination events might occur generating a recombinant EBV carrying the 'therapeutic' genes. Considering tion. This was confirmed by Southern blot analysis which demonstrated the episomal state of the vectors without the pleiotropic growth stimulating and activating effects of cytokines the use of such mini-EBVs for cytokineany evidence of integration into the host cell genome. By comparison, the lower rate of stable transfected cells mediated gene therapy might be dangerous. In contrast, the vectors presented in this work, permit using the pKEX-derived vectors reflected loss of episomal plasmid DNA shortly after transfection and the longthe introduction of cytokine genes in lymphoma cells as non-integrative, self-replicating, extrachromosomal genterm persistence exclusively of vector DNA integrated into the host cell genome, as also demonstrated by Southetic units. Thus, they avoid the hazards of integration into the host cell genome as well as those of using infecern blot analysis.
Expression analysis after transfection of the tious particles. In addition, they are easy to handle and possess a high cloning capacity. Owing to their structural EBNA1/oriP vectors revealed high cytokine concentrations in the supernatant of proliferating cells and high and functional similiarity to the EBV genome these vectors are expected to be functional also, when they contain levels of intracellular CAT protein, respectively, in BL60 as well as in BJA-B cells. With the exception of TNF␣, multiple inserts. Thus, bi-or polycistronic vectors can be constructed, eg vectors containing the cytokine cDNA expression levels were higher with EBNA1/oriP vectors compared with pKEX-derived vectors. Moreover, and together with a suicide gene (HSVtk) and/or the cDNA encoding for the second signal molecule B7. To restrict also in contrast to pKEX-derived vectors, with the EBNA1/oriP vectors expression levels of a given cytothe expression of these vectors after transfection the CMV promotor could be replaced through cell-type-specific kine differed only slightly between different transfected clones of the same cell line as well as between the two promoters. The p1-myc promoter for example would lead to expression exclusively in B cells. 38 Taken together, our cell lines tested. This observation confirmed the absence of position effects on gene expression due to vector inteexperiments suggest that these BC219-derived vectors may represent an effective tool for cytokine gene transfer gration when using the EBNA1/oriP vectors.
In contrast to the BJA-B cell line, BL60 cells transfected in human lymphoma cells. with the pKEX vectors did not express cytokines or the CAT gene at all. This observation was surprising, since
Materials and methods
integration of the pKEX vectors in the genome of BJA-B was demonstrated by Southern blot analysis. In addition, Basic expression vectors expression of transfected genes in BL60 cells using a Vector pKEX-2XR (Figure 1a ) was described by Rittner et pKEX vector has already been described. 30, 31 Possibly the al. 29 The 6.8 kb plasmid carries the human cytomegalointegration process led to destruction of the vector. This virus immediate-early (HCMV-IE) promoter-enhancer was suggested by the results of Southern blot analysis, element, the simian virus 40 (SV40)-derived small T-antiwhere the addition of the length of the integrated vector gen splice and late region polyadenylation signal and the fragments did not result in the length of the whole plashygromycin B resistance gene. Vector BC219 (Figure 1b ) mid.
was described by Polack et al. 39 Briefly, the 13.9 kb plasMaintenance of expression of the EBNA1/oriP vectors mid carries the EBV latent origin of replication (oriP), and was also analyzed without hygromycin B selection press-EBNA1 leading to episomal persistence of the plasmid in ure. In vitro as well as in nude mouse tumors, cytokine eucaryotic cells. Beside the HCMV-IE promoter-enhancer expression could be measured over several weeks but, it carries additional enhancer elements for increase of however, declined continuously. In the 4th week after expression, namely the matrix attachment region (MAR), removing hygromycin B the expression level of IL6 was the intron and the 3′ enhancer elements of the human approximately 50% of the initial level, and after about 2
Ig kappa light chain gene locus. 39 BC230a contains the more weeks approximately 25%. Thus, these vectors canchloramphenicolacetyltransferase (CAT) gene as a SfiI not be used for gene therapeutic strategies where longfragment and BC-DZ17 contains the lacZ gene, cloned term gene expression is essential, as for instance introinto the NaeI site of BC219. duction of a multidrug resistance gene in hematopoietic stem cells or substitution of gene defects as in Gaucher's disease. However, for inducing an antitumor immune Construction of expression vectors cDNAs of the human cytokines IL6 and TNF␣ were purresponse by cytokine transfection of tumor cells they represent a suitable tool.
chased from the American Type Culture Collection (ATCC, Rockville, MD, USA). The CAT gene was kindly provided Recently, a vector has been described which also carries the EBV genomic elements EBNA1 and oriP to allow by M von Knebel-Döberitz (DKFZ Heidelberg, Germany). Standard cloning techniques were used as described. 40 For fragment, BC-GM-CSF from the EcoRI-cDNA 43 and BC-TNF␣ from the PstI-TNF␣ cDNA. 42 construction of pKEX-CAT the CAT coding sequence was isolated as a HincII fragment and cloned into the SmaI site of pKEX-2XR. For construction of pKEX-IL6 the IL6-cDNA Plasmid preparation For transfection, plasmids were amplified in E. coli strain was isolated as an EcoRI-HindIII fragment from the vector pGEMII-2.
41 After blunt-end formation with the Klenow Sure cells (Stratagene), isolated using the Ish Horowitz method 40 and purified by cesium chloride gradient cenfragment of DNA polymerase I the fragment was inserted into the SmaI site of pKEX-2XR. For construction of pKEXtrifugation. The DNA was dialysed against 10 mm Tris, 1 mm EDTA, pH 8 (TE), ethanol-precipitated and resus-TNF␣ the TNF␣ cDNA was isolated as a PstI fragment of the vector pE4, 42 cloned into the Bluescript vector pBS M13 pended in sterile water. KS (Stratagene, La Jolla, CA, USA), cut out as a XhoI-XbaI fragment and ligated to the XhoI-XbaI sites of pKEX-2XR.
Cell lines BL60-P7 is a neomycin-resistant and hypoxanthine-guanFor cloning cytokine cDNAs into BC219, they were first cloned into pBS*, a variant of pBS M13 KS with a different ine-phosphoribosyltransferase (HGPRT)-deficient subline of the Burkitt's lymphoma cell line BL60. 13 BJA-B is an polylinker site, namely SacI-SfiI-PstI-EcoRI-XbaI-HindIIIXhoI-BamHI-SfiI-KpnI. It was constructed to provide cyto-EBV-negative B cell lymphoma cell line. 44 Cells were cultured in RPMI-1640 medium (GIBCO Laboratories, kine cDNAs with a SfiI site before cloning into BC219. BC-IL6 was constructed from the EcoRI-HindIII-IL6 cDNA Grand Island, NY, USA) supplemented with 10% heat- The values given represent cytokine concentrations in the supernatant of the most productive and the less productive clone. Each value is a mean of two independent measured values. Measurements were performed using ELISA (Quantikine, Biermann, Germany). inactivated fetal calf serum (FCS), 2 mm glutamine, 100 IU penicilline and 100 g streptomycin/ml.
Transfection BL60-P7 and BJA-B cells were transfected using the electroporation method. 45 Briefly, 2 × 10 7 cells and 20 g DNA in a total volume of 200 l PBS were placed in an electroporation chamber with an electrode distance of 4 mm. A high voltage of 200 V (BJA-B), respectively 220 V (BL60-P7), was applied with an electropulsing device, capacitance 1050 microfarads (Easyject, Eurogentec, Belgium). After 5 min on ice, 15 ml of growth medium was added, and cells were incubated for 24 h. Then, cells were plated on 96-well microtiter plates at a concentration of 2 × 10 5 cells/l for selection of hygromycin Bresistant clones (400 g hygromycin/ml medium). Clones of transfected cells were identified 21 days after transfection and were transferred into 24-well microtiter plates.
Enzyme-linked immunosorbent assay (ELISA)
Concentrations of human cytokines IL6, TNF␣ and GM-CSF in cell culture supernatants were determined by a commercially available ELISA (Quantikine), distributed by Biermann, Bad Nauheim, Germany. Cells were plated 24 h before measurement in fresh medium at a concentration of 1 × 10 6 cells/l without hygromycin B. ELISA was performed according to the manufacturer's instructions. The sensitivity thresholds were: 0.35 pg/ml (IL6), 0.17 pg/ml (TNF␣) and 1.5 pg/ml (GM-CSF). CAT protein in cell lysates was measured with a CAT-ELISA (Boehringer-Mannheim, Mannheim, Germany) by using 50 g of total protein extract. cols. 40 After restriction enzyme digestion 10 g of cleaved
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